Patents by Inventor Sarah Catoen

Sarah Catoen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipophilic macrocyclic ligands, complexes thereof, and uses of same
    Patent number: 11261166
    Abstract: The present invention relates to novel lipophilic macrocyclic ligands, the complexes thereof, in particular radioactive complexes, and the uses of same in medical imaging and/or in therapy, in particular in interventional radiology.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: March 1, 2022
    Assignee: GUERBET
    Inventors: Olivier Rousseaux, Olivier Fougere, Sarah Catoen
  • LIPOPHILIC MACROCYCLIC LIGANDS, COMPLEXES THEREOF, AND USES OF SAME
    Publication number: 20200231554
    Abstract: The present invention relates to novel lipophilic macrocyclic ligands, the complexes thereof, in particular radioactive complexes, and the uses of same in medical imaging and/or in therapy, in particular in interventional radiology.
    Type: Application
    Filed: July 20, 2018
    Publication date: July 23, 2020
    Inventors: Olivier ROUSSEAUX, Olivier FOUGERE, Sarah CATOEN
  • Radiolabeled macrocyclic EGFR inhibitor
    Patent number: 10716869
    Abstract: The present invention relates to 18-Fluor radiolabeled macrocyclic quinazoline compounds, which are suitable as positron emission tomography (PET) tracers for imaging epidermal growth factor receptors (EGFR), and their use in in vivo diagnosis, preclinical and clinical tumour imaging, patient stratification on the basis of mutational status of EGFR, and assessing tumour response to therapeutic treatments. The present invention also describes precursor compounds and methods of preparing the radiotracers. The invention is relevant to any cancer that is influenced or driven by deregulated EGFR, such as, but not limited to, non-small cell lung cancer (NSCLC), pancreatic, hepatocellular, oesophageal, gastric, colorectal, prostate, cervical, renal, ovarian, breast cancers, head and neck squamous cell carcinoma, and malignant glioma.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: July 21, 2020
    Assignee: Oncodesign SA
    Inventors: Jan Marie Cyriel Jozef Hoflack, Cyril Berthet, Petra Marcella Françoise Blom, Johnny Vercouillie, Caroline Robic, Sarah Catoen, Gilles Voit, Jean-Bernard Deloye
  • RADIOLABELED MACROCYCLIC EGFR INHIBITOR
    Publication number: 20190054197
    Abstract: The present invention relates to 18-Fluor radiolabeled macrocyclic quinazoline compounds, which are suitable as positron emission tomography (PET) tracers for imaging epidermal growth factor receptors (EGFR), and their use in in vivo diagnosis, preclinical and clinical tumour imaging, patient stratification on the basis of mutational status of EGFR, and assessing tumour response to therapeutic treatments. The present invention also describes precursor compounds and methods of preparing the radiotracers. The invention is relevant to any cancer that is influenced or driven by deregulated EGFR, such as, but not limited to, non-small cell lung cancer (NSCLC), pancreatic, hepatocellular, oesophageal, gastric, colorectal, prostate, cervical, renal, ovarian, breast cancers, head and neck squamous cell carcinoma, and malignant glioma.
    Type: Application
    Filed: February 28, 2017
    Publication date: February 21, 2019
    Applicant: Oncodesign SA
    Inventors: Jan Marie Cyriel Jozef Hoflack, Cyril Berthet, Petra Marcella Françoise Blom, Johnny Vercouillie, Caroline Robic, Sarah Catoen
  • IMAGING AGENTS AND THEIR USE FOR THE DIAGNOSTIC IN VIVO OF NEURODEGENERATIVE DISEASES, NOTABLY ALZHEIMER'S DISEASE AND DERIVATIVE DISEASES
    Publication number: 20120263646
    Abstract: Disclosed are new imaging agents and their use for the in vivo diagnostic of neurodegenerative diseases, notably Alzheimer's disease and related diseases.
    Type: Application
    Filed: October 15, 2010
    Publication date: October 18, 2012
    Applicant: GUERBET
    Inventors: Sarah Catoen, Thierry Gautheret